Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Viatris Inc
(NQ:
VTRS
)
11.59
+0.16 (+1.40%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 4, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Viatris Inc
< Previous
1
2
...
6
7
8
9
10
11
12
13
Next >
India-Based Biocon To Buy Viatris' Biosimilars Assets In $3.3B Deal
February 28, 2022
Biocon Biologics Ltd has agreed to acquire Viatris Inc's (NASDAQ: VTRS) biosimilars assets for up to $3.335 billion in stock and cash. The deal value...
Via
Benzinga
Viatris: Q4 Earnings Insights
February 28, 2022
Viatris (NASDAQ:VTRS) reported its Q4 earnings results on Monday, February 28, 2022 at 06:00 AM. Here's what investors need to know about the announcement. Earnings...
Via
Benzinga
Earnings Scheduled For February 28, 2022
February 28, 2022
Companies Reporting Before The Bell • Lexicon Pharmaceuticals (NASDAQ:LXRX) is estimated to report earnings for its fourth quarter. • Praxis Precision Medicine (...
Via
Benzinga
The Week Ahead In Biotech (Feb. 27-March 5): Earnings, Multiple Regulatory Decisions Take The Spotlight
February 27, 2022
Biopharma stocks lock-stepped with the broader market in the week ending Feb. 25 before finishing higher. The trajectory was the same, with the sector declining in the first...
Via
Benzinga
A Bullish Sign Appears On Viatris's Chart
February 16, 2022
If history is any guide, there may be good fortune ahead for shares of Viatris (NASDAQ:VTRS). A so-called "golden cross" has formed on its chart and, not surprisingly, this could...
Via
Benzinga
The Week Ahead In Biotech (Feb. 6-12): Pfizer, AstraZeneca Earnings, Conference Presentations, & More
February 06, 2022
Biotech stocks managed to close the week with gains. Stocks recovered along with the broader markets early in the week, but came under pressure midweek amid some big pharma earnings. The sector came...
Via
Talk Markets
The Week Ahead In Biotech (Feb. 6-12): Pfizer, AstraZeneca Earnings, Conference Presentations, IPOs And More
February 06, 2022
Biotech stocks managed to close the week ending Feb. 4 with gains. Stocks recovered along with the broader markets early in the week, but came under pressure midweek amid negative reaction to some big...
Via
Benzinga
14 Stocks in the Healthcare Sector
January 21, 2022
Here are 14 companies in the Healthcare Sector that have investment-grade credit ratings of BBB- or better, cash flow yield of 6% or better, future total return of at least 5%.
Via
Talk Markets
Viatris Recalls One Batch Of Diabetes Treatment Semglee Citing Missing Label Risks
January 20, 2022
Viatris Inc's (NASDAQ: VTRS) Mylan will pull one batch of non-interchangeable Semglee, also known as insulin glargine injection. The Company cited the risk of the...
Via
Benzinga
7 Pharmaceutical Stocks That Could Make You Rich
January 06, 2022
Due to expiring patents and rising competition, successful pharmaceutical stocks need to develop robust drug pipelines. 7 Pharmaceutical Stocks That Could Make You Rich
Via
InvestorPlace
7 of the Best Cheap Stocks Under $20 for 2022 to Buy Now
January 03, 2022
These cheap stocks are trading at highly attractive prices and have the potential to break through this year.
Via
InvestorPlace
10 Worst Performing S&P 500 Stocks Of 2021
December 31, 2021
The S&P 500 delivered one of its best years in recent history in 2021, gaining more than 27%. Most U.S. investors had a lot of winners in their portfolios this year, but some...
Via
Benzinga
7 of the Best Value Stocks for 2022 to Buy Now
December 15, 2021
Among the best value stocks, these seven provide both deep value and upside potential. Buy now for future gains in 2022.
Via
InvestorPlace
Jim Cramer Shares His Warning On Nio, Expresses Support For TJX And More
December 14, 2021
On CNBC’s "Mad Money Lightning Round," Jim Cramer said he doesn’t like NIO Inc. (NYSE:
Via
Benzinga
India's Biocon Mulls Merger Of Biosimilar Business With Mylan: Moneycontrol
December 09, 2021
India-based Biocon Ltd is reportedly in talks with generic drugmaker Mylan for a merger of their biosimilar businesses, financial news website ...
Via
Benzinga
The Daily Biotech Pulse: Adcom Backs Merck's Oral COVID-19 Treatment; Regulatory Setbacks For CTI Biopharma, BioXcel; Favorable Ruling For Viatris In Tecfidera Patent Case
December 01, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck Gets Adcom Backing For Oral COVID-19 Antiviral Medication Molnupiravir...
Via
Benzinga
Topics
Intellectual Property
Exposures
COVID-19
Intellectual Property
7 Drug Stocks to Buy Now While They’re Still on Sale
November 30, 2021
Covid-19 stocks soared to unsustainable highs as investors ignored drug stocks with a deep pipeline of products for the decade ahead.
Via
InvestorPlace
Topics
Supply Chain
Exposures
COVID-19
Supply Chain
Biogen Loses Bid To Revive Tecfidera Drug Patent: Bloomberg
November 30, 2021
Biogen Inc (NASDAQ: BIIB) lost its appeals court bid to revive a key patent on the blockbuster multiple sclerosis drug Tecfidera, reports Bloomberg. In a related ruling...
Via
Benzinga
Topics
Intellectual Property
Exposures
Intellectual Property
Is It Too Late to Buy Viatris Stock?
November 30, 2021
It's not too late if you're looking for dividend income.
Via
The Motley Fool
7 Stocks 'On Sale' This Holiday Season
November 26, 2021
This time of year, it may feel like you’ve missed out on big rallies in the best stocks. But, there may still be a chance to buy some high-quality stocks for 2022 at a discount to what you would have...
Via
Talk Markets
7 Stocks 'On Sale' This Holiday Season
November 26, 2021
The SPDR S&P 500 ETF Trust (NYSE: SPY) has generated a total return of 26.4% year-to-date, but much of those overall gains have been driven by a handful of megacap stocks. In...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
3 Pharma Stocks That Are Too Cheap to Ignore
November 25, 2021
Many stocks are ridiculously expensive right now -- but not these three.
Via
The Motley Fool
Novartis May Have Buyer(s) For Its Sandoz Unit - Report
November 23, 2021
According to a German newspaper, Swedish-based investment group EQT and the Struengmann family of Germany are considering a joint move to purchase the Novartis AG...
Via
Benzinga
New Alternatives for Branded Biologics
November 22, 2021
We’ve all heard about generic drugs. They are time-tested and battle-proven medicines that are more affordable than their patented predecessors. Branded drugs consistently...
Via
Benzinga
7 Stocks to Buy for Their Resistance to the 6.2% Monthly Inflation
November 22, 2021
These companies either have no exposure to inflation or have strong branding and customer loyalty, enabling them to pass higher costs.
Via
InvestorPlace
3 Things About Viatris That Smart Investors Know
November 21, 2021
Don't expect it to follow the trajectory of a hot growth stock.
Via
The Motley Fool
Johnson & Johnson Pops As It Announces The Biggest Split In Health Care
November 12, 2021
Johnson & Johnson will split its consumer health unit into a publicly traded company.
Via
Investor's Business Daily
The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More
November 08, 2021
Biotech stocks reversed course and closed the week ended Nov. 5 lower, squandering the gains notched early in the week. What was good news for Pfizer, Inc. (NYSE: PFE) turned out...
Via
Benzinga
Earnings Scheduled For November 8, 2021
November 08, 2021
Companies Reporting Before The Bell • Privia Health Group (NASDAQ:PRVA) is projected to report quarterly loss at $0.11 per share on revenue of $215.14 million. •...
Via
Benzinga
Could Viatris Stock Help You Retire a Millionaire?
October 23, 2021
It depends on how much help you're looking for.
Via
The Motley Fool
Topics
Retirement
Exposures
Pension
< Previous
1
2
...
6
7
8
9
10
11
12
13
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.